Johnson & Johnson Raises Outlook as MedTech Sales Miss, Shares Slide
Johnson & Johnson reported better-than-expected profit and raised its full-year outlook, while MedTech sales of $8.64 billion came in below the $8.71 billion analyst estimate. Shares fell 5.73% to $248.61.